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The interest of psychiatric patients for complementary medicine, such as acupuncture, is stable, but effect studies in psychiatry
remain scarce. In this pilot study, the effects of 3 months of acupuncture treatment on sleep were evaluated and compared between
a group of patients with schizophrenia (𝑛 = 16) and a group with depression (𝑛 = 16). Healthy controls were included in order
to establish reference values (𝑛 = 8). Patients with schizophrenia and depression were randomly assigned to either a waiting
list or a treatment condition. The Pittsburgh Sleep Quality Inventory was completed before and after the acupuncture treatment
(individualized and according to traditional Chinese medicine principles) or the waiting list condition. Both acupuncture groups
showed significant lower scores on the sleep inventory, which was not the case for the waiting list condition. Moreover, it was
found that the effectiveness of the acupuncture treatment was higher in the patients with schizophrenia than in the patients with
depression. Acupuncture seems able to improve sleep in this convenient sample of patients with long-lasting psychiatric problems
and may be a suitable and cost-effective add-on treatment for this group, particularly if conducted group-wise.
1. Introduction
Interest in complementary and alternative medicine (CAM),
such as acupuncture, has increased in popularity in Western
societies in the last part of the twentieth century and there
has been a continued interest ever since [1]. The use of
CAM includes its application in psychiatric patients [2].
Two large groups that need long-term treatment are patients
with depression and patients with schizophrenia. Besides
the typical depressive or positive and negative symptoms,
their disorders are characterized by marked disturbances
of sleep [3–8]. Patients with schizophrenia show increased
sleep latency, decreased total sleep time, and decreased sleep
efficiency [3–5]. A bidirectional relationship between insom-
nia and depressive symptoms in patients with depression
is described [6–8]. Sleep problems such as increased sleep
latency, awakenings in the night or early in the morning
with an incapability to go back to sleep, and decreased
sleep efficiency are typical symptoms of depression, whereas
hypersomnia and dream disturbances are also often reported.
The sleep disorders appear tomaintain or even deteriorate the
mood disorder [9].
InWestern psychiatry, a growing consumption of antipsy-
chotic [10] and antidepressant drugs [11] can be seen.Antipsy-
chotic application is seen as the cornerstone in therapy for
patients with schizophrenia [12], whereas due to their positive
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effects, antidepressants have found their place in the clinical
guidelines for the treatment of, for instance, patients with
depression [13]. Despite these clinical successes, a problem
with pharmaceutical therapies [14], like any other therapy, is
that they are subject to patient nonadherence and declining
patient compliance [15, 16].
Previous research has shown that adherence to treatment
correlates negatively with sleep disturbance and depression
[17]. It seems that a lack of contact with this patient group
makes it difficult to engage in a therapeutic relationship or to
prescribe and monitor medication effectively. The medicines
used to treat these conditions often cause drowsiness [18].
Patients are therefore often advised to take them at night
which causes problems with sleep (e.g., excessive dreaming
and increase in total sleep time in patients with schizophrenia
[4]), even though taking them at night minimizes daytime
drowsiness. Moreover, tiredness, drowsiness, and poor sleep
interfere with the patient’s ability to engage with therapeutic
services because they are too tired, unmotivated and they
do not see the point or do not want to take medicines that
cause such adverse effects. Presumably, these are not the only
factors that are of importance, but they seem highly relevant
in patient groups that suffer from depression, as well as those
that suffer from schizophrenia, since both diseases are prone
to sleep disorders.
Acupuncture is part of Traditional Chinese Medicine
(TCM), which in itself is a form of CAM that is based on
thousands of years of practice [21]. One of the features of the
TCM approach is the individualization of treatment, which
relies on a symptom-based diagnostic process [22]. TCM
diagnoses are based on clinical symptoms and signs that are
completely discerned by the oriental medical practitioner
[22].
Recent years have seen an increase in trials on particu-
larly depression and acupuncture [23–25]. Various reviews,
however, have concluded that evidence for the effects of
acupuncture on depression still remains preliminary [26–
28]. In particular methodological problems, such as different
techniques (electro-, manual, or laser acupuncture), various
control groups and study designs limit the generalization
of the results [23, 29]. Although efforts have been made to
standardize and optimize research and the way it is reported,
further research is warranted [26, 30].
Even less research with acupuncture has been conducted
on schizophrenia. Some literature research [31, 32] indicates
that more research is necessary to draw firm conclusions on
acupuncture’s effectiveness in the treatment of schizophrenia.
Moreover, even though some research was reported [33, 34],
hinting in the direction of effectiveness and thereby providing
the basis for future research, the existing research remains
preliminary.
Acupuncture may be beneficial in the treatment of sleep
disorders [35]. It can be used alone or combined with
other interventions, since no interactions were found to date
and adverse events related to treatment seem sufficiently
controllable by providing thorough training [36]. Although
some research has been conducted on acupuncture and sleep
disorders [37–40], results are still tentative, particularly in
patients with psychiatric disorders. Results call for research in
a group, in which symptoms are prominent, since acupunc-
ture’s effectiveness is thought to rely on its homeostatic
actions, striving to return the body to its normal physiological
state. Therefore, it is thought that acupuncture has more
effects on patients that experience serious problems than on
healthy participants or patients with only mild symptoms
[41].
This pilot study evaluates and compares the effects of
acupuncture on the subjective quality of sleep in long-term
patients with schizophrenia and patients with depression. It
is a pragmatic trial and a first start to conduct research in an
integrative treatment setting in which psychiatric treatment
and TCM are combined.
2. Materials and Methods
2.1. Participants. In total the convenient sample consisted of
40 participants (13 men, 27 women). Sixteen of them (10
women, 6 men, mean age was 44.25 years, SD = 2.44) were
diagnosed with schizophrenia, 16 of them (12 women, 4 men,
mean age was 50.94 years, SD = 1.33) were diagnosed with
depression. The healthy control group consisted of 5 women
and 3 men (mean age was 36.75 years, SD = 12.43). Mean
length of illness was 13.56 years (SD = 1.59) for the group with
schizophrenia and 5.94 years (SD = 1.05) for the group with
depression.The randomization function in Excel was used to
randomly divide the patients into a treatment and a waiting
list condition. For an overview of the descriptive statistics
see Table 1 and for an overview of the medication used see
Table 2.
Recruiting limitations resulted in a higher mean age in
the depression waiting list condition than in the healthy
control group (𝑃 < 0.05). There was a poster in the entrance
section and in the waiting room that gave information
on the study. Moreover, potential participants (diagnosed
with schizophrenia F20.0 (paranoid schizophrenia), F20.5
(schizophrenic residuum), or depression F33.2 according
to the ICD-10) [42] were identified and approached by
their therapist at the LVR-Klinik Bedburg-Hau. Patients
that agreed to participate did so voluntarily and signed an
informed consent form; moreover, their therapist signed
for their mental ability to understand the form. The Becks
Depression Inventory-II [43] and Positive And Negative
Symptom Scale (PANSS) [44] were used as inclusion criteria.
The study was carried out in accordance with the Declaration
of Helsinki [45] and was approved by the ethical committee
of the A¨rztekammer Nordrhein. Participants continued with
their normal psychiatric treatment, including medication,
alongside acupuncture. After the project, the medical files
were checked for possible changes in medication during
the time of the project. Moreover, possible use of sleep
medication was mentioned by the patients on the Pittsburgh
Sleep Quality Inventory (PSQI). Five of the patients with
schizophrenia (all in the acupuncture condition) used sleep
medication beforehand. Six of the patients with depression
(2 in the acupuncture and 4 in the waiting list condition)
and none of the healthy control group used sleep medication.
Of the five patients in the schizophrenia and acupuncture
Evidence-Based Complementary and Alternative Medicine 3
Table 1: Overview of the descriptive statistics of the convenient sample.
Schizophrenia (SD) Depression (SD) Healthy control (SD)
Total Waiting list Acupuncture Total Waiting list Acupuncture Total
Men 6 3 3 4 2 2 3
Women 10 5 5 12 6 6 5
Length of illness 13.56 (1.59) 12.63 (5.90)a 14.50 (7.07)a 5.94 (1.05) 4.38 (3.54) 7.50 (4.41) 0
Age 44.25 (2.44) 42.25 (10.99) 46.25 (8.57) 50.94 (1.33) 52.88 (5.59)b 49.00 (4.54) 36.75 (12.43)
According to the one-way ANOVA (groups as between subjects factor) at baseline: aMean is significantly different (𝑃 < 0.05) from the depression waiting list
group. bMean is significantly different (𝑃 < 0.05) from the healthy control group.
Table 2: Overview of the medication used by the different groups at the start of the study.
Group CPZ Atypical Typical SSRI Tricyclicantidepressives
SNRI and
SSNRI Others
Depression and
acupuncture group
Chlorprothixene in 1 patient
Promethazine in 1 patient
Pipamperone in 1 patient
0.33 in 1 patient
In 2
patients
In 2
patients
In 4
patients
In 3
patients
In 3
patients
In 2
patients
Depression and
waitlist group
Pipamperone in 1 patient
0.33 in 1 patient
In 1
patient
In 1
patient
In 4
patients
In 2
patients
In 3
patients
In 2
patients
Schizophrenia and
acupuncture group
Amisulpride + 1 in 1 patient
Zotepine + 1 in 1 patient
Prothipendyl + 2 in 1 patient
Fluphenazine + 3 in 1 patient
6 in 1 patient
4 in 1 patient
3.5 in 1 patient
1.83 in 1 patient
In 8
patients
In 3
patients
In 0
patients
In 1
patient
In 1
patients
In 4
patients
Schizophrenia and
waitlist group
Fluphenazine + 3 in 1 patient
6 in 1 patient
Pipamperone + 3.17 in 1 patient
1.83 in 1 patient
1 in 1 patient
Zotepine and Chlorprothixene
and Melperone + 4 in 1 patient
10 in 1 patient
3.5 in 1 patient
In 8
patients
In 3
patients
In 0
patients
In 2
patients
In 0
patients
In 4
patients
CPZ (Chlorpromazine Equivalents) were calculated using published equivalencies for oral conventional [19] and atypical [20] antipsychotics.
SSRI: selective serotonin reuptake Inhibitor, SNRI: serotonin norepinephrine reuptake inhibitor, SSNRI: selective serotonin norepinephrine reuptake inhibitor.
group, one of them used Prothipendyl (80mg daily), one
used Prothipendyl (40mg daily), one used Sifrol (0.36mg
daily) one used Amitriptyline (50mg daily), and one used
Melperone (75mg daily). In the depression and acupunc-
ture group one patient used Chlorprothixene (30mg daily)
and one patient Pipamperone (40mg daily). Finally in the
depression and waiting list condition group one patient used
Pipamperone (40mg daily) and three patients Zopiclone
(7.5mg daily/when needed). Probably due to the natural
course of the diseases and recruitment limitations, the group
of participants diagnosed with schizophrenia had been in
treatment significantly longer than those with depression.
There were no gender differences within and between the
groups. Exclusion criteria for the patients were substance
abuse and/or epilepsy and other neurological conditions. For
the control group, the exclusion criteria were the presence of
neurological or psychiatric disorders.
2.2. Instruments
2.2.1. Pittsburgh SleepQuality Inventory. TheGerman version
of the PSQI [46] was used in order to gain information on the
subjective quality and quantity of sleep in the participants.
This retrospective list contains questions about sleep during
the last four weeks, information on the number of sleep dis-
turbances, estimation on sleep quality, sleep duration, sleep
latency and sleep times, use of medication, and sleepiness
during the day.The questionnaire consists of 18 items, divided
into 7 components that can be scored from 0 to 3. The PSQI
Total Score results in the sum of the component scores and
can be any score from zero to 21. A high score means sleep
quality is bad. Five was originally seen as the cutoff score.
Participants that score below 5 have a good sleep quality.
However, there is a tendency to use 6 as a cutoff score [47] to
be more selective. The internal consistency for the American
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and Japanese versions was found to be good. Cronbach’s
alpha for the total score was .77 [48]. The validity of the
PSQI in patients with primary insomnia was good, since
a high correlation between PSQI scores and a sleep diary
was obtained by Backhaus and colleagues [49]. Moreover,
they found a significant correlation between the PSQI and
polysomnographic measurements. These results were con-
firmed in research on the Chinese version of the PSQI [50]. In
all, the PSQI has a high sensitivity and specificity for patients
with insomnia [49] and also for patients with depression and
schizophrenia [48].
2.3. Experiment
2.3.1. Needles. Theneedles (AcuPro C,Wujiang City Cloud&
DragonMedical Device Co., Ltd., China) that were used were
0.25 × 25mm or 0.20 × 15mm stainless steel (depending on
the place of needling) single-use needles. The needles were
placed according to TCM principles.
2.3.2. Intervention. The participants in the acupuncture
groupswere given acupuncture treatment once aweek, twelve
weeks in a row. Individualized acupuncture according to
TCMprinciples was applied after careful individual diagnosis
by a licensed oriental medical practitioner with more than
5 years of clinical experience [30]. Acupuncture treatment
took place in a light room with (very) soft background
music (Enya) playing. According to the demand of the ethics
committee to decrease anxiety [51] as much as possible in
patients with schizophrenia and to make them feel comfort-
able, music along with acupuncture was used. The music was
kept constant over all participants and all sessions. There
were 12 “relax” chairs in which it was possible to adjust the
back and put the feet up, resulting in a near-lying position.
It was, however, also possible to remain upright; this was left
to the patients to decide for themselves. Due to the fact that
acupuncture was applied with patients in a sitting or near-
lying position, access to acupuncture points on the back was
limited. Patients came into the room in intervals, in order to
reduce waiting time. Treatment (after needles were inserted)
lasted for one hour. After this hour, needles were removed.
This group treatment setting made sure practitioners were
directly at hand in case anxiety would arise and it was one of
the important points that were made in the dialogue with the
ethics committee. In case individuals had personal questions
or sensitive matters that needed to be discussed prior to
treatment, there was an empty room next to the treatment
room where confidentiality could be assured. As there were
two acupuncturists present, the other patients would not be
left alone in the mean time.
All participants continued with regular treatment includ-
ing appointments with their psychiatrists; this was not influ-
enced by the project since acupuncturewas used as an add-on
treatment.
2.3.3. Procedure. All participants were tested in an exper-
imental testing room in the clinic, by apprentices who
were blind to group or time of testing. The healthy control
group was tested at T1 (pretest) only. The participants with
schizophrenia and depression were tested at T1 and T2
(posttest). After the tests at T1, participants were randomly
divided into a treatment and a waiting list condition. The
duration of the whole experiment was 13 weeks, which
included 12 weekly acupuncture sessions and pre- and post-
testing. At the end of the experiment, all participants received
a debriefing and were individually informed about their
own test results. Patients on the waiting list were given
the opportunity to attend acupuncture treatment after T2 if
they wanted to. The current study stopped at T2, although
acupuncture treatment was given after T2 in order to provide
equal treatment opportunities. The patients, however, were
not tested afterwards and therefore these data were not
included in the study. Moreover, any acupuncture that was
provided after the study was part of their normal treatment,
not of any study.
2.4. Statistics. Differences between the five groups on the
subtests of the PSQI before the start of the treatment were
analyzed with a one-way analysis of variance (one-way
ANOVA) with groups as between subjects factor, followed
by posthoc (Bonferroni) tests. Repeated measures analyses
of variance were used to analyze possible differences on the
PSQI Total Score and on the subtests of the PSQI pre- and
posttreatment (in the four experimental groups), followed
by posthoc (Bonferroni) t-tests if appropriate, that is, t(7) in
our pilot-study. A value of 𝑃 < 0.05 was considered to be
statistically significant.
3. Results
3.1. Acupuncture Points That Were Used. For more details see
Table 3.
3.2. Pretest Results. Descriptive characteristics of the five dif-
ferent groups are shown in Table 4, as well as the outcomes of
the posthoc tests following the one-way ANOVA. On some
of the subtests differences were found between the healthy
control and the psychiatric groups.
3.3. Evaluation of Sleep Quality between the Groups. All pa-
tients randomized and treated over 12weeks in the depression
and schizophrenia groups were analyzed (each 𝑛 = 8). As can
be seen in Table 5, post hoc t-tests for each subtest and group
separately resulted in the following significant differences: the
depression acupuncture group showed a significant reduction
for PSQI Total Score t(7) = 4.333, 𝑃 = 0.003. For the
depression waiting list condition, no significant differences
were found between the pre- and posttest measurements.
A significant reduction for the schizophrenia acupuncture
group was found for PSQI Total Score t(7) = 2.393, 𝑃 = 0.048,
for PSQI Latency t(7) = 2.553, 𝑃 = 0.038, for PSQI Disorders
t(7) = 2.646, 𝑃 = 0.033, and for PSQI Medicine t(7) = 2.646,
𝑃 = 0.033. No differences were found for the schizophrenia
waiting list condition.
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Table 3: Acupuncture points that were used.
Points/patients D1 D2 D3 D4 D5 D6 D7 D8 S1 S2 S3 S4 S5 S6 S7 S8
EX-HN-1 12 12 12 12 12 12 11 12 12 11 12 12 11 12 12 12
DU-24 2 5 5 2 8
DU-14 1
DU-17 1
DU-18 1 1
DU-19 1
EX-HN-3 5 1 2
EX-HN-5 5 1 2 1
LI-20 1
ST-8 10 3 3 9 8 7 2 7 5 10 1 2 1
ST-7 1
ST-6 2
TB-21 1 1
KI-23 2
KI-24 1 2 1
KI-25 1 1
KI-26 1
GB-6 1
GB-7 1
GB-8 1 1
GB-13 2 1 2 1 9
GB-20 2 1
SI-3 5 11 2 2 1
SI-4 1
SI-5 2
HT-2 1
HT-3 1 4 3 3 1 4 2
LI-4 12 12 12 12 12 12 12 12 7 3 5 9 10 8 12 4
PC-6 3 2 1 4 2 1 1 2 1 1 1
PC-7 1 4 2 5 4 2 1 2 1 7
HT-7 12 12 11 12 12 12 12 12 9 1 7 3 3 8 3
HT-8 1
LU-5 1 1
LU-6 8
LU-7 1 11 8 5 3 3 12 8 1 3 5 1
TB-5 5 10 3 2 2
TB-6 1
LI-7 1 2 1 2 10 2 1 1 1
LI-11 6 6 3 12 10 1 12 6 5 10 8 8 8 11 12 11
CV-12 2
CV-14 1
CV-15 1
CV-16 1 1
CV-17 7 2 3 7 10 1 7 9 12 3 6 9 9 8 11
CV-18 2 3 1
ST-21 3 4
ST-25 4 2 1 3 5 1 3
CV-5 1
CV-4 3 8 9 2 9
KI-10 1 2
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Table 3: Continued.
Points/patients D1 D2 D3 D4 D5 D6 D7 D8 S1 S2 S3 S4 S5 S6 S7 S8
SP-10 7 6 9 2 3 1 1
BL-39 1
BL-40 1 3
SP-9 12 12 12 12 11 12 12 12 7 6 10 9 12 12 12 3
GB-34 8 7 5 7 8 6 5 6 1 1 4
ST-36 12 12 12 8 12 12 2 12 7 1 3 8 9 8 9 2
ST-40 1 1 12 11 1 10 9 3 2 4 2 9
SP-6 12 12 12 12 12 12 12 11 11 4 12 8 12 11 12 10
KI-3 11 12 12 12 12 12 12 12 1 2 4 7 11 12
KI-5 2
KI-6 9 8 9 5 8 12 2 2
LR-3 10 12 11 12 10 4 7 10 10 9 6 8 10 9 5 7
LR-1 2 2 4
SP-4 4 4 1 11 4 7 9 7 1 2
BL-60 2 2 1 3
BL-62 2
ST-44 2 7 1 3 7
ST-45 6 2 1 1
GB-41 1 1
GB-44 3 9 6 2 1 5 4 2
GB-45 1
BL-67 1 1 6 5 3 2 1 1 11 1
Eye of the knee 8 3 5 6
BAXIE 3
D: patient with depression, S: patient with schizophrenia.
Table 4: Corrected means and SDs of the PSQI subtest scores at baseline (T1) for all groups.
PSQI subtest Schizophrenia Schizophrenia Depression Depression Healthy (SD)
waiting list (SD) acupuncture (SD) waiting list (SD) acupuncture (SD)
Total score 5.75 (1.91) 8.50b (4.21) 9.63b (4.57) 8.50b (3.02) 3.50 (2.07)
Subjective sleep quality 1.00 (0.76) 1.00 (0.76) 1.63 (0.52) 1.38 (0.52) 0.75 (0.46)
Latency 0.87 (1.36) 1.88 (1.13) 1.50 (1.07) 1.50 (0.93) 0.50 (0.54)
Duration 0.25 (0.46) 0.38 (1.06) 1.00 (1.41) 0.50 (0.93) 0.63 (0.74)
Efficiency 1.38 (1.51) 1.00 (1.07) 1.13 (1.55) 1.00 (1.31) 0.25 (0.71)
Disorders 0.88 (0.35) 1.38 (0.52) 1.63 (0.74) 1.50 (0.54) 0.88 (0.35)
Medication 0.00a (0.00) 1.88b (1.55) 1.25 (1.49) 0.75 (1.39) 0.00 (0.00)
Daytime sleepiness 1.38 (0.52) 1.00b (0.76) 1.50 (0.93) 1.88 (0.84) 0.50 (0.54)
According to the one-way ANOVA (groups as between subjects factor) and post hoc tests at baseline: aMean is significantly different (𝑃 < 0.05) from the
schizophrenia acupuncture group. bMean is significantly different (𝑃 < 0.05) from the healthy control group.
3.4. Side Effects. Two patients reported bruising as a side
effect after one of the acupuncture treatment sessions. More-
over, one patient reported having been extremely tired after
the first session. Otherwise, no side effects were reported.
4. Discussion
In this pilot study, the effects of three months of acupuncture
treatment on subjective sleep quality were investigated in a
group of patients with schizophrenia and a group of patients
with depression that were diagnosed by their therapists
according to the ICD-10 [42]. All patients were chronically
ill. Significant improvements were found on the PSQI Total
Score for both treatment groups, indicating that patients
slept better after 12 acupuncture treatments. The waiting list
condition groups showed no significant improvements. As
was suggested byHametner and colleagues [47], a cutoff score
of 6 can be used in order to clinically divide patients with
sleep problems from patients with good sleep. The patient
group with schizophrenia falls below this clinically relevant
score after treatment. The patient group with depression has
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Table 5: Corrected pretest (T1) means of the PSQI for all five groups and posttest (T2) means of the PSQI for the four groups with patients.
PSQI subtest Schizophrenia waiting list Schizophrenia acupuncture Depression waiting list Depression acupuncture Healthy control
T1 T2 𝑃 T1 T2 𝑃 T1 T2 𝑃 T1 T2 𝑃 T1
Total score 5.75 4.88 0.576 8.50 5.50 0.048∗ 9.63 9.00 0.493 8.50 6.88 0.003∗∗ 3.50
Subjective
quality 1.00 0.75 0.170 1.00 0.50 0.170 1.63 1.50 0.685 1.38 1.00 0.080 0.75
Latency 0.87 0.75 0.732 1.88 0.75 0.038∗ 1.50 1.63 0.685 1.50 1.12 0.197 0.50
Duration 0.25 0.13 0.598 0.38 0.63 0.351 1.00 0.75 0.451 0.50 0.63 0.351 0.63
Efficiency 1.38 0.63 0.365 1.00 1.50 0.407 1.13 1.38 0.563 1.00 0.75 0.170 0.25
Disorders 0.88 0.88 1.00 1.38 0.88 0.033∗ 1.63 1.63 1.00 1.50 1.13 0.080 0.88
Medication 0.00 0.38 0.351 1.88 0.38 0.033∗ 1.25 0.13 0.094 0.75 0.75 1.00 0.00
Daytime
sleepiness 1.38 1.38 1.00 1.00 0.88 0.685 1.50 2.00 0.104 1.88 1.50 0.080 0.50
Difference T1-T2 within the groups: ∗𝑃 < 0.05, ∗∗𝑃 < 0.005.
improved and although the differences might not seem large,
they seem borderline clinically relevant.
Three subscales (PSQI Latency, PSQI Medication, and
PSQI Disorders) showed significant improvements in the
schizophrenia group, but not in the depression group. This
indicates that the patients with schizophrenia took more
benefit from acupuncture than the patients with depres-
sion. Of note, these patients fell asleep faster and even
approached normal levels on the subtest (PSQI Latency),
meaning that patients with schizophrenia lay awake less long
before falling asleep after acupuncture treatment and that
they reached levels that are commonly found in healthy
controls. They also used less medication in order to sleep
and reached normative levels also on the subtest for sleep
disorders. Five of the patients with schizophrenia (from the
acupuncture condition) used sleep medication of different
kinds beforehand, whereas four of them answered that they
had stopped using this medication during the time of the
acupuncture treatment. Moreover, one of the patients in the
waiting list condition of this group, who had not used sleep
medication beforehand, started using sleep medication. On
the other hand, six of the patients with depression (two in
the acupuncture group and four in the waiting list condition)
used sleep medication beforehand of which 4 (in the waiting
list condition) stopped using this medication and one of the
other patients in the waiting list group started to use sleep
medication. There were no differences between or within
the depression groups on medication use as reported by the
patient.
The intervention phase lasted three months (12 treat-
ments) only. Future studies might consider whether the nov-
elty factor of this intervention or the short-term availability
implies that patients are more likely to attend. It is not known
whether patients would be so keen to attend acupuncture
were it available as part of their normal treatment package.
There were no withdrawals from the acupuncture or waiting
list groups in this study. In this clinic, as part of the normal
treatment package, patients can choose to visit treatment
groups like, for instance; a psychosis education group, sleep
training, depression group, social competency training group
or a memory training. All of these groups last 10 to 12 times
and have a dropout rate between 30 to 40%.These differences
between the regular groups and this study might be caused
by the small amount of appointments in the waiting list
condition as well as a positive experience in the acupuncture
groups. This impression is supported by the absent dropout
and the comments made by participants (that reported, for
instance: feeling less tired, more relaxed, and better able to
sleep), that they were satisfied with the treatment and keen
to have it. On the other hand, it is important to note that
the participants were largely self-selecting (as they are in
every group they attend in this clinic) and therefore more
likely to come to the treatments anyway. However, in order
to draw more firm conclusions, it would have been better to
implement a measure of treatment satisfaction in the study.
Some participants reduced their medication, in consul-
tation with their psychiatrist, as a result of the acupuncture
treatment. These participants saw this as a benefit of the
acupuncture.Medication reduction is usually seen as positive
by patients. It is felt to be a sense of improvement or
achievement. It may be that the promise of a reduction
in medication through acupuncture may be a motivational
factor for attendance at acupuncture treatments. On the other
hand, it is important to note that there are possible pitfalls
in reducing medication as well. It has been described that
patients with schizophrenia who improve through the use
of acupuncture and as a result reduce or even stop taking
medication may become more vulnerable to breakdown
[52]. Further research is needed to confirm these subjective
comments that were reported by the patients in this study
and to investigate the possibility that acupuncture may be
misused as an excuse for nonadherence with conventional
medication.
Limitations. Since the study involves acupuncture, it is obvi-
ous that the problemof the absence of a suitable control group
or placebo needs to be mentioned [30]. In this study, it was
chosen to investigate the “normal” or “real-world” manual
individualized acupuncture treatment that any patient would
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receive if they should go to an oriental medical practitioner.
The use of a standardized protocol for acupuncture is,
besides theNational AcupunctureDetoxificationAssociation
(NADA) protocol that is used for addiction and trauma
[53], unheard of in clinical TCM practice. The use of such
a standardization would therefore not shed any light on
the possible effect that an acupuncture add-on treatment
(that patients seek outside our psychiatric clinics) would
have on patients and would not be generalisable to routine
clinical practice [54]. In this study, a pragmatic randomized
controlled trial (RCT) was used; this approach attempts
to answer a “real-world” question whether acupuncture as
add-on treatment improves sleep more than without this
treatment. Our overall goal was to deliver better treatment
to patients and this implies that we have to evaluate what can
be done in daily practice. MacPherson [55] paraphrased this
issue by stating that “the question in acupuncture research
should be rather whether acupuncture is of better value
than what is currently on offer instead of asking whether
acupuncture is better than placebo?”
Due to the ethical problems related to discontinu-
ing treatment with antipsychotic and antidepressant drugs,
patients continued their medication during the study. We
have listed the doses in Chlorpromazine equivalents and
information on medication that was used in Table 2. Due
to the fact that psychiatric patients use a wide variety of
medication, it was not possible, within the convenient sample
in our monocenter pilot study, to include only those that use
the same medication and medication doses.
One more limitation of the study is the fact that a second
baseline might have been used; it is recommended for future
research.
Since the ethics committee required group treatments due
to the fact that a practitioner needed to be present at all times,
a limitation was that some participants talked to each other
before, during, or after treatment sessions. It was not possible
to control for the content of these conversations.
Finally, the number of patients in the present study is rel-
atively small. Therefore, in further research it is necessary to
increase the sample size, though, despite the small numbers,
significant improvements in sleep quality were found.
There is anxiety about giving acupuncture to people with
schizophrenia in Europe, since it is not normally practiced
and people in psychiatric hospitals are not normally left alone
with needles or other dangerous objects. Moreover, anxiety
exists about the needles becoming part of hallucinations
or psychotic thoughts. For instance, patients might think
that they are being radiographic controlled through the
needles. The present study further proves that people with
schizophrenia can be safely treatedwith acupuncture and that
the use of needles did not evoke negative emotional reactions.
It is important to realize that in this pilot study, positive
results were obtained in a group of patients with schizophre-
nia that have been ill for more than 10 years. Length of
illness was analyzed more specifically and it was found that,
although there was a difference between the schizophrenia
and depression experimental and waiting list groups when it
comes to this factor, it did not account for themore significant
results in the group with schizophrenia.
It is obvious that the positive outcomes of this pilot study
warrant further and larger-scale research, but the tentative
conclusion is that the present study shows that acupuncture
seems to influence sleep in a positive way in sleep-disturbed
patients and seems a suitable add-on treatment in psychiatry,
even in patients with long-term depression or schizophrenia.
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